Enantiomers of myo-inositol-1,3,4-trisphosphate and myo-inositol-1,4,6 -trisphosphate: stereospecific recognition by cerebellar and platelet myo-inositol-1,4,5-trisphosphate receptors

C. T. Murphy, A. Bullock, C. J. Lindley, S. J. Mills, A. Riley, B. V. L. Potter, J. Westwick

Research output: Contribution to journalArticle

13 Citations (Scopus)
Original languageEnglish
Pages (from-to)1223-1230
JournalMolecular Pharmacology
Volume50
Issue number5
Publication statusPublished - 1996

Cite this

Enantiomers of myo-inositol-1,3,4-trisphosphate and myo-inositol-1,4,6 -trisphosphate: stereospecific recognition by cerebellar and platelet myo-inositol-1,4,5-trisphosphate receptors. / Murphy, C. T.; Bullock, A.; Lindley, C. J.; Mills, S. J.; Riley, A.; Potter, B. V. L.; Westwick, J.

In: Molecular Pharmacology, Vol. 50, No. 5, 1996, p. 1223-1230.

Research output: Contribution to journalArticle

@article{e3892340955745228e02fb37bfdf0a1b,
title = "Enantiomers of myo-inositol-1,3,4-trisphosphate and myo-inositol-1,4,6 -trisphosphate: stereospecific recognition by cerebellar and platelet myo-inositol-1,4,5-trisphosphate receptors",
author = "Murphy, {C. T.} and A. Bullock and Lindley, {C. J.} and Mills, {S. J.} and A. Riley and Potter, {B. V. L.} and J. Westwick",
year = "1996",
language = "English",
volume = "50",
pages = "1223--1230",
journal = "Molecular Pharmacology",
issn = "0026-895X",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "5",

}

TY - JOUR

T1 - Enantiomers of myo-inositol-1,3,4-trisphosphate and myo-inositol-1,4,6 -trisphosphate: stereospecific recognition by cerebellar and platelet myo-inositol-1,4,5-trisphosphate receptors

AU - Murphy, C. T.

AU - Bullock, A.

AU - Lindley, C. J.

AU - Mills, S. J.

AU - Riley, A.

AU - Potter, B. V. L.

AU - Westwick, J.

PY - 1996

Y1 - 1996

UR - http://molpharm.aspetjournals.org/content/50/5/1223.full.pdf+html

M3 - Article

VL - 50

SP - 1223

EP - 1230

JO - Molecular Pharmacology

JF - Molecular Pharmacology

SN - 0026-895X

IS - 5

ER -